胰腺癌的当前流行病学：挑战与机遇。
Current epidemiology of pancreatic cancer: Challenges and opportunities.
作者信息
Luo Wenhao, Tao Jinxin, Zheng Lianfang, Zhang Taiping
机构信息
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
出版信息
Chin J Cancer Res. 2020 Dec 31;32(6):705-719. doi: 10.21147/j.issn.1000-9604.2020.06.04.
Abstract
Pancreatic cancer (PC) is an increasingly common disease worldwide. Having a better understanding of worldwide and regional epidemiologic features and risk factors of PC is essential to identify new approaches for prevention, early diagnosis, surveillance, and treatment. In this article, we review the epidemiologic features and risk factors for PC and discuss opportunities and challenges of PC future treatment.
摘要
胰腺癌（PC）在全球范围内是一种日益常见的疾病。更好地了解全球及地区胰腺癌的流行病学特征和风险因素，对于确定预防、早期诊断、监测及治疗的新方法至关重要。在本文中，我们综述了胰腺癌的流行病学特征和风险因素，并讨论了胰腺癌未来治疗的机遇与挑战。
相似文献
1
Current epidemiology of pancreatic cancer: Challenges and opportunities.胰腺癌的当前流行病学：挑战与机遇。
Chin J Cancer Res. 2020 Dec 31;32(6):705-719. doi: 10.21147/j.issn.1000-9604.2020.06.04.
2
Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer.当前胰腺癌化学预防的挑战和机遇。
Curr Med Chem. 2018;25(22):2535-2544. doi: 10.2174/0929867324666170209104453.
3
Genomics in Primary and Secondary Prevention of Pancreatic Cancer.胰腺癌一级和二级预防中的基因组学
Public Health Genomics. 2017;20(2):92-99. doi: 10.1159/000477234. Epub 2017 Jul 8.
4
Epidemiology of pancreatic cancer: New version, new vision.胰腺癌流行病学：新版本，新视野。
Chin J Cancer Res. 2023 Oct 30;35(5):438-450. doi: 10.21147/j.issn.1000-9604.2023.05.03.
5
High risk factors of pancreatic carcinoma.胰腺癌的高危因素。
J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):295-304. doi: 10.1007/s11596-016-1583-x. Epub 2016 Jul 5.
6
Pancreatic cancer: medical aspects.胰腺癌：医学方面
Pancreas. 1998 Apr;16(3):349-54. doi: 10.1097/00006676-199804000-00023.
7
Screening for Pancreatic Cancer.胰腺癌筛查
Surg Clin North Am. 2016 Dec;96(6):1223-1233. doi: 10.1016/j.suc.2016.07.016.
8
Pancreatic Cancer Surveillance: Who, When, and How.胰腺癌监测：对象、时机与方式。
Curr Treat Options Gastroenterol. 2019 Dec;17(4):681-691. doi: 10.1007/s11938-019-00247-0.
9
Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.胰腺癌：免疫系统在癌症进展及基于疫苗的免疫治疗中的作用
Hum Vaccin Immunother. 2014;10(11):3354-68. doi: 10.4161/hv.34392.
10
Detecting Early Pancreatic Cancer: Current Problems and Future Prospects.早期胰腺癌的检测：当前问题与未来展望。
Gut Liver. 2020 Jan 15;14(1):30-36. doi: 10.5009/gnl18491.
引用本文的文献
1
TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.触发受体表达于髓样细胞-1（TREM-1）作为治疗胰腺导管腺癌的新型免疫治疗靶点。
Mol Ther Oncol. 2025 Aug 14;33(3):201034. doi: 10.1016/j.omton.2025.201034. eCollection 2025 Sep 18.
2
Pancreatic cancer mortality trend in Montenegro, 1990-2018.1990 - 2018年黑山共和国胰腺癌死亡率趋势
Gastroenterol Rep (Oxf). 2025 Aug 11;13:goaf076. doi: 10.1093/gastro/goaf076. eCollection 2025.
3
Mushroom Bioactive Molecules as Anticancerous Agents: An Overview.蘑菇生物活性分子作为抗癌剂：综述
Food Sci Nutr. 2025 Jul 14;13(7):e70580. doi: 10.1002/fsn3.70580. eCollection 2025 Jul.
4
Evaluating the Impact of Oral Contraceptives on Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Analysis.评估口服避孕药对胰腺癌风险的影响：一项两样本孟德尔随机化分析
Biomedicines. 2025 May 31;13(6):1351. doi: 10.3390/biomedicines13061351.
5
BE-43547A exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting its association with FoxO1.BE-43547A通过靶向真核延伸因子1A1（eEF1A1）并破坏其与叉头框蛋白O1（FoxO1）的结合，对人胰腺癌细胞发挥缺氧选择性抑制作用。
Acta Pharmacol Sin. 2025 May;46(5):1433-1444. doi: 10.1038/s41401-024-01461-y. Epub 2025 Jan 21.
6
Pancreaticoduodenectomy after Roux-en-Y gastric bypass and novel endoscopic ultrasound-directed transgastric ERCP procedure.Roux-en-Y胃旁路术后的胰十二指肠切除术及新型内镜超声引导下经胃逆行胰胆管造影术
J Surg Case Rep. 2024 Dec 2;2024(12):rjae762. doi: 10.1093/jscr/rjae762. eCollection 2024 Dec.
7
TULP4 degrades RYBP to enhance DNA damage repair and chemosensitivity of pancreatic ductal adenocarcinoma.TULP4降解RYBP以增强胰腺导管腺癌的DNA损伤修复和化疗敏感性。
Genes Dis. 2024 Apr 5;12(2):101288. doi: 10.1016/j.gendis.2024.101288. eCollection 2025 Mar.
8
In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader.基于 WGCNA 和 Trader 的胰腺导管腺癌治疗靶点的计算机识别
Sci Rep. 2024 Oct 7;14(1):23292. doi: 10.1038/s41598-024-74252-4.
9
Cytotoxic Impact of Naringenin-Loaded Solid Lipid Nanoparticles on RIN5F Pancreatic β Cells Autophagy Blockage.柚皮素载药固体脂质纳米粒对 RIN5F 胰腺β细胞的细胞毒性作用 自噬阻断。
Recent Adv Drug Deliv Formul. 2024;18(4):304-314. doi: 10.2174/0126673878297658240804192222.
10
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.自噬相关基因多态性作为胰腺癌易感性生物标志物的研究：三个大型欧洲队列的荟萃分析及功能特征分析。
Int J Cancer. 2025 Jan 15;156(2):339-352. doi: 10.1002/ijc.35196. Epub 2024 Sep 25.
本文引用的文献
1
Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period.埃及尼罗河三角洲地区十二年间胰腺癌发病率的区域差异
J Cancer Epidemiol. 2020 Jul 14;2020:6031708. doi: 10.1155/2020/6031708. eCollection 2020.
2
Pancreatic cancer.胰腺癌。
Lancet. 2020 Jun 27;395(10242):2008-2020. doi: 10.1016/S0140-6736(20)30974-0.
3
Pancreatic cancer in Australia: is not it time we address the inequitable resource problem?澳大利亚的胰腺癌：是否到了解决资源分配不均问题的时候了？
Future Oncol. 2020 Jul;16(19):1385-1392. doi: 10.2217/fon-2020-0109. Epub 2020 May 15.
4
A nomogram to preoperatively predict 1-year disease-specific survival in resected pancreatic cancer following neoadjuvant chemoradiation therapy.一种用于术前预测新辅助放化疗后切除的胰腺癌1年疾病特异性生存率的列线图。
Chin J Cancer Res. 2020 Feb;32(1):105-114. doi: 10.21147/j.issn.1000-9604.2020.01.12.
5
Projected estimates of cancer in Canada in 2020.2020 年加拿大癌症预估。
CMAJ. 2020 Mar 2;192(9):E199-E205. doi: 10.1503/cmaj.191292.
6
Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.近期 1A 期胰腺癌发病和生存趋势：监测、流行病学和最终结果分析。
J Natl Cancer Inst. 2020 Nov 1;112(11):1162-1169. doi: 10.1093/jnci/djaa004.
7
Incidence and risk factors for post-operative mortality, hospitalization, and readmission rates following pancreatic cancer resection.胰腺癌切除术后的死亡率、住院率及再入院率的发生率和危险因素。
J Gastrointest Oncol. 2019 Dec;10(6):1080-1093. doi: 10.21037/jgo.2019.09.01.
8
Vitamin D Status May Help Explain Racial Disparities in Pancreatic Cancer Incidence and Mortality in the United States.维生素D状况可能有助于解释美国胰腺癌发病率和死亡率的种族差异。
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1896. doi: 10.1016/j.cgh.2019.12.033. Epub 2020 Jan 8.
9
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.新诊断胰腺癌患者静脉血栓栓塞症的发生率及其与结局相关的因素。
Gastroenterology. 2020 Apr;158(5):1346-1358.e4. doi: 10.1053/j.gastro.2019.12.009. Epub 2019 Dec 14.
Zotero 插件